Thorough overview of ubiquitin C‐terminal hydrolase‐L1 and glial fibrillary acidic protein as tandem biomarkers recently cleared by US Food and Drug Administration for the evaluation of intracranial injuries among patients with traumatic brain injury

Traumatic brain injury (TBI) is a major cause of mortality and morbidity affecting all ages. It remains to be a diagnostic and therapeutic challenge, in which, to date, there is no Food and Drug Administration‐approved drug for treating patients suffering from TBI. The heterogeneity of the disease a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kevin K.W., Kobeissy, Firas H., Shakkour, Zaynab, Tyndall, J. Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814989/
https://www.ncbi.nlm.nih.gov/pubmed/33510896
http://dx.doi.org/10.1002/ams2.622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814989/
https://www.ncbi.nlm.nih.gov/pubmed/33510896
http://dx.doi.org/10.1002/ams2.622

Ejemplares similares